Publications by authors named "Matthew D Galsky"

100Publications

Incidence and Risk of Colitis With Programmed Death 1 Versus Programmed Death Ligand 1 Inhibitors for the Treatment of Cancer.

J Immunother 2020 Nov/Dec;43(9):291-298

Department of Medicine, Division of Oncology, Icahn School of Medicine at Mount Sinai, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000339DOI Listing
September 2020

Treatment of muscle-invasive and advanced bladder cancer in 2020.

CA Cancer J Clin 2020 Aug 7. Epub 2020 Aug 7.

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3322/caac.21631DOI Listing
August 2020

TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancer.

Urol Oncol 2020 Jul 11. Epub 2020 Jul 11.

Department of Urology; Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2020.06.007DOI Listing
July 2020

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.

Lancet 2020 06 28;395(10241):1907-1918. Epub 2020 May 28.

Vanderbilt-Ingram Cancer Center at Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(20)31187-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255743PMC
June 2020

Urothelial carcinoma: the development of FGFR inhibitors in combination with immune checkpoint inhibitors.

Expert Rev Anticancer Ther 2020 Jun 21;20(6):503-512. Epub 2020 Jun 21.

Department of Medicine, Division of Hematology and Medical Oncology, the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai , New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2020.1770600DOI Listing
June 2020

Selective PP2A Enhancement through Biased Heterotrimer Stabilization.

Cell 2020 Apr 20;181(3):688-701.e16. Epub 2020 Apr 20.

Division of Genetic Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48105, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2020.03.038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243596PMC
April 2020

Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial.

Prostate Cancer Prostatic Dis 2020 Apr 20. Epub 2020 Apr 20.

Department of Medicine, Division of Hematology and Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41391-020-0231-5DOI Listing
April 2020

Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma.

Urol Oncol 2020 08 10;38(8):684.e9-684.e15. Epub 2020 Apr 10.

Department of Urology, Icahn School of Medicine at Mount Sinai, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2020.03.008DOI Listing
August 2020

A reference profile-free deconvolution method to infer cancer cell-intrinsic subtypes and tumor-type-specific stromal profiles.

Genome Med 2020 02 28;12(1):24. Epub 2020 Feb 28.

Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13073-020-0720-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049190PMC
February 2020

Comparative Effectiveness of Robotic-Assisted Surgery for Resectable Lung Cancer in Older Patients.

Chest 2020 May 4;157(5):1313-1321. Epub 2019 Oct 4.

Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY; Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2019.09.017DOI Listing
May 2020

What Is the Significance of Variant Histology in Urothelial Carcinoma?

Eur Urol Focus 2020 07 15;6(4):653-663. Epub 2019 Sep 15.

Division of Surgery, Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2019.09.003DOI Listing
July 2020

Clinical Complete Response after Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Call for Standardized Assessments and Definitions.

Eur Urol Focus 2020 07 5;6(4):627-629. Epub 2019 Sep 5.

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2019.08.009DOI Listing
July 2020

The clinical and economic burden of perioperative complications of radical cystectomy.

Transl Androl Urol 2019 Jul;8(Suppl 3):S277-S279

Department of Urology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tau.2019.03.04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642960PMC
July 2019

Conditionally Reprogrammed Patient-derived Cells: A Step Forward Towards Personalized Medicine?

Eur Urol 2019 10 18;76(4):435-436. Epub 2019 Jul 18.

Division of Hematology and Oncology, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.07.015DOI Listing
October 2019

The natural history of untreated muscle-invasive bladder cancer.

BJU Int 2020 02 7;125(2):270-275. Epub 2019 Aug 7.

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.14872DOI Listing
February 2020

Atezolizumab in "Real World" Patients: Do Phase 3b Trials Help Bridge the Gap Between Efficacy and Effectiveness?

Eur Urol 2019 07 19;76(1):82-83. Epub 2019 Apr 19.

Division of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.04.004DOI Listing
July 2019

A delay ≥8 weeks to neoadjuvant chemotherapy before radical cystectomy increases the risk of upstaging.

Urol Oncol 2019 Feb 1;37(2):116-122. Epub 2018 Dec 1.

Division of Urology, VA Long Beach Healthcare System, Long Beach, CA; Department of Urology, University of California, Irvine, Orange, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2018.11.011DOI Listing
February 2019

Current Role of Checkpoint Inhibitors in Urologic Cancers.

Cancer Treat Res 2018;175:241-258

Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-3-319-93339-9_11
Publisher Site
http://dx.doi.org/10.1007/978-3-319-93339-9_11DOI Listing
June 2019

Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import.

Cell 2018 08 9;174(5):1200-1215.e20. Epub 2018 Aug 9.

Cancer Biology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Pathology Department, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2018.07.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150493PMC
August 2018

Premature Clinical Trial Discontinuation in the Era of Immune Checkpoint Inhibitors.

Oncologist 2018 12 1;23(12):1494-1499. Epub 2018 Aug 1.

Department of Medicine, Division of Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292544PMC
December 2018

Resistance to prostate-cancer treatment is driven by immune cells.

Authors:
Matthew D Galsky

Nature 2018 07;559(7714):338-339

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/d41586-018-05460-yDOI Listing
July 2018

Effectiveness of Transurethral Resection plus Systemic Chemotherapy as Definitive Treatment for Muscle Invasive Bladder Cancer in Population Level Data.

J Urol 2018 11 4;200(5):996-1004. Epub 2018 Jun 4.

Division of Hematology/Oncology, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00225347184331
Publisher Site
http://dx.doi.org/10.1016/j.juro.2018.06.001DOI Listing
November 2018

Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer.

World J Urol 2018 Nov 2;36(11):1741-1748. Epub 2018 Jun 2.

Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-018-2359-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207464PMC
November 2018

Bladder cancer in 2017: Advancing care through genomics and immune checkpoint blockade.

Authors:
Matthew D Galsky

Nat Rev Urol 2018 02 28;15(2):71-72. Epub 2017 Nov 28.

Department of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, New York 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2017.199DOI Listing
February 2018

Web-Based Tool to Facilitate Shared Decision Making With Regard to Neoadjuvant Chemotherapy Use in Muscle-Invasive Bladder Cancer.

JCO Clin Cancer Inform 2017 11;1:1-12

Matthew D. Galsky, Nihal Mohamed, Charles Baker, Sumit Pokhriya, Jason Rogers, Ashish Atreja, Liangyuan Hu, Che-Kai Tsao, John Sfakianos, Reza Mehrazin, Nikhil Waingankar, William K. Oh, Madhu Mazumdar, and Bart S. Ferket, Icahn School of Medicine at Mount Sinai, New York; and Michael Diefenbach, Northwell Health, Great Neck, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/CCI.17.00116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874030PMC
November 2017

Telemedicine-Enabled Clinical Trial of Metformin in Patients With Prostate Cancer.

JCO Clin Cancer Inform 2017 11;1:1-10

Matthew D. Galsky, Mohamed Shahin, Rachel Jia, Kiev Gimpel-Tetra, Che-Kai Tsao, Charles Baker, Amanda Leiter, Reza Mehrazin, John P. Sfakianos, Patricia Acon, and William K. Oh, Icahn School of Medicine at Mount Sinai; John Holland, AMC Health; Tomasz Sablinski, Transparency Life Sciences, New York; and David R. Shaffer, Albany Medical Center, Albany, NY.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/CCI.17.00044
Publisher Site
http://dx.doi.org/10.1200/CCI.17.00044DOI Listing
November 2017

Moving beyond vascular endothelial growth factor-targeted therapy in renal cell cancer: latest evidence and therapeutic implications.

Ther Adv Med Oncol 2017 Apr 14;9(4):287-298. Epub 2017 Feb 14.

Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1758834016687261
Publisher Site
http://dx.doi.org/10.1177/1758834016687261DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405995PMC
April 2017

A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity.

Oncologist 2017 05 24;22(5):609-619. Epub 2017 Apr 24.

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2016-0319DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423518PMC
May 2017

Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Are Things Now Getting Personal?

Eur Urol 2017 10 19;72(4):555-556. Epub 2017 Apr 19.

Department of Population Health Science and Policy, Institute for Healthcare Delivery Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.04.012DOI Listing
October 2017

The role of GATA2 in lethal prostate cancer aggressiveness.

Nat Rev Urol 2017 Jan 22;14(1):38-48. Epub 2016 Nov 22.

Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2016.225DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489122PMC
January 2017

Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.

Urol Oncol 2016 12 9;34(12):556-565. Epub 2016 Nov 9.

Division of Hematology & Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2016.10.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709811PMC
December 2016

Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer.

Urol Oncol 2016 12 17;34(12):530.e15-530.e21. Epub 2016 Oct 17.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2016.07.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464417PMC
December 2016

Phase I Study of CHK1 Inhibitor LY2603618 in Combination with Gemcitabine in Patients with Solid Tumors.

Oncology 2016 7;91(5):251-260. Epub 2016 Sep 7.

START Madrid, Centro Integral Oncológico Clara Campal, Madrid Norte Sanchinarro University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000448621DOI Listing
January 2017

Definitive Management of Primary Bladder Tumors in the Context of Metastatic Disease: Who, How, When, and Why?

J Clin Oncol 2016 10;34(29):3495-3498

Icahn School of Medicine at Mount Sinai, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.3714DOI Listing
October 2016